期刊文献+

药物的球形结晶技术 被引量:4

Spherical Crystallization Technique of Drugs
原文传递
导出
摘要 球结晶是通过控制重结晶中药物分子相互聚合过程,可得到较大粒径球形药物颗粒的技术,作为新型的粒子设计方法,该技术可改善粉体性质(包括流动性、可压缩性、生物利用度等)、控制过程参数(温度、搅拌速率、溶剂种类和用量、辅料种类等)、得到理想粒径分布的球形颗粒。本文综述了国内外药剂学领域球结晶技术的相关研究,着重介绍了经典的球结晶制备方法(球形聚集法、类乳浊液溶剂扩散法、氨扩散法和结晶共聚法),从工业扩大生产的角度,在制备方法、过程参数及粉体性能方面提出了一些想法,为该技术在药物的应用与推广方面提供参考。 Spherical crystallization is a technology to obtain spherical drugs with large particle size by controlling polymerization process of drug molecules during crystallization. As a new method of particle design, this technique can improve powder properties, including flowability, compressibility, bioavailability and so on, control process parameters and obtain spherical particles with desired particle size distribution. Process parameters during crystallization includes temperature, stirring rate, type and amount of solvents etc. This paper focuses on four classical techniques for obtaining spherical particles and give viewpoint on its industrial enlargement.
作者 裴小玲 嵇扬
出处 《中国实验方剂学杂志》 CAS CSCD 北大核心 2015年第12期210-216,共7页 Chinese Journal of Experimental Traditional Medical Formulae
基金 国家"重大新药创制"科技重大专项(2009ZXJ09004-083) 军队特需药品专项
关键词 球结晶 粉体改性 球形聚集 类乳浊液溶剂扩散法 氨扩散法 结晶共聚 晶癖 spherical crystallization powder modification spherical agglomeration quasi-emulsion solvent diffusion ammonia diffusion method crystalline copolymer crystal habit
  • 相关文献

参考文献67

  • 1Kovaeie B, Vreeer F, Planinek O. Spherical crystallization of drugs[J].Acta Pharm ,2012,62 : 1-14.
  • 2Chaumeil J C. Micronization:a method of improving the bioavailability of poorly soluble drugs [ J ]. Methods Find Exp Clin Pharmacol, 1998,20 ( 3 ) : 211-215.
  • 3Feeley J C,York P,Sumby B S. Determination of surface properties and flow characteristics of salbutamol sulphate, before and after micronisation [ J ]. Int J Pharm, 1998,172 ( 1/2 ) : 89-96.
  • 4De Villiers M M. Influence of cohesive properties of micronized drug powders on particle size analysis [ J ]. J Pharm Biom Anal,1995,13(3):191-198.
  • 5Tiwary A K,Jindal M. Crystal habit changes and dosage form performance, in encyclopedia of pharmaceutical technology[ M ]. 3rd ed. New York: Taylor & Francis, 2006 : 820-833.
  • 6Kaul D, Nguyen N T, Venkataram S. Crystal habit modifications and altered tabletting characteristics [ J ]. Int J Pharm, 1992,88 ( 1/3 ) : 345 -350.
  • 7Garekani H A, Sadeghi F, Badiee A. Crystal habit modifications of ibuprofen and their physicochemical characteristics[J]. Drug Dev Ind Pharm,2001,27 (8) : 803 -809.
  • 8Rasenack N, Mllller B W. Ibuprofen crystals with optimized properties[ J]. Int J Pharm ,2002,245 ( 1/2 ) : 9 -24.
  • 9Morris K R, Griesser U J, Eckhardt C J. Theoretical approaches to physical transformations of active pharmaceutical ingredients during manufacturing processes [ J ]. Adv Drug Del Rev, 2001,48 ( 1 ) : 91 - 114.
  • 10Andreassen J P. Formation, mechanism and morphology in precipitation of vaterite-nano-aggregation or crystal growth [J]. Cryst Growth, 2005,274 ( 1/2 ) : 256-264.

同被引文献67

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部